The change of personnel at the Department of Health following Gordon Brown’s reshuffle has also given the campaign extra urgency.
‘It adds impetus,’ said ABPI head of media relations Richard Ley. ‘There are new ministerial teams in these departments and perhaps messages need to be communicated in a different way in the period when negotiations are starting.’
The scheme is the ongoing mechanism to decide the price paid by the NHS to manufacturers for branded, prescription medicines. In 2004 the government demanded a seven per cent drop in price from companies with NHS sales above £1m.
But last week the Government said it was open to negotiation. The ABPI has emphasised the relatively low cost of UK drugs.